Disubstituted ureas as kinase inhibitors

Details for Australian Patent Application No. 2006204505 (hide)

Owner Novartis AG

Inventors Rasetti, Vittorio; Furet, Pascal; McCarthy, Clive; Vaupel, Andrea; MartinyBaron, Georg

Agent Davies Collison Cave

Pub. Number AU-A-2006204505

PCT Pub. Number WO2006/072589

Priority 0500435.3 10.01.05 GB

Filing date 9 January 2006

Wipo publication date 13 July 2006

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/072589 Priority application(s): WO2006/072589

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204506-A device of determining uniformity of a batch of seeds

2006204498-Treatment apparatus